Conceivable Life Sciences
PrivateLast Round
Series A
Aug 5, 2025
Total Funding Raised
$103.1M
Momentum
Top 25%
of companies Caplight tracks
Company Overview
Conceivable Life Sciences operates in Healthcare & Life Sciences and is based in New York City, New York. Its latest recorded funding round was a Series A round in August 2025.
Conceivable Life Sciences is a healthcare technology company that develops a fully automated, AI-powered IVF laboratory platform designed to improve precision, quality, and scalability in fertility treatments.
Sector
Healthcare & Life Sciences
Verticals
Biotechnology, Medical Devices, Medical AI, Industrial Robotics, Workflow Automation
Business Model
B2B2C
Customer Profile
Hardware + Subscription, Services & Consulting
AI Layer
Application
Historical Pricing
Historical view of private secondary pricing and transaction trends.
Conceivable Life Sciences Comparables
Compare Conceivable Life Sciences with similar companies based on industry and business-model similarity.
| Company | Similarity | Market Cap |
|---|---|---|
| Overture Life | 89% | |
| MIM Fertility | 78% | |
| SpOvum Technologies Private Limited | 77% |
For institutional investors. Book with your work email.
Conceivable Life Sciences Funding Rounds
Historical fundraising activity
| Round | Date | Amount Raised | Valuation | Investors | Sources |
|---|---|---|---|---|---|
| Series A | Aug 5, 2025 | ||||
| Series A | Jan 14, 2025 | ||||
| Debt | Dec 17, 2024 | ||||
| Seed | Dec 1, 2022 |
For institutional investors. Book with your work email.
Key People
Founding team and executive leadership
For institutional investors. Book with your work email.
Conceivable Life Sciences Investors
Notable investors and investment history
| Investor | Rounds |
|---|---|
| Time BioVentures | Series A, Seed |
| Cadence Healthcare Ventures | Series A, Seed |
| ARTIS Ventures | Series A, Seed |
| Muse Capital | Series A |
| Advance Venture Partners | Series A |
| Atlantic Health Venture Studio | Series A |
| Sherpa Capital | Series A, Seed |
For institutional investors. Book with your work email.
Market signals
Structured signals derived from secondary market and firmographic data.
- Jul 25, 2026
Monthly visitors grew 101% MoM, reaching 7.4K.
- Feb 24, 2026
Launched world's first AI-powered automated IVF laboratory.
For institutional investors. Book with your work email.
Conceivable Life Sciences Filings
Explore SEC and related filing metadata, where available.
| Type | Date | Amount Offered | Amount Sold | Filing | Pages | Download |
|---|
Filing documents are not displayed on this public page. Request access to learn about available coverage.
Book a demoFor institutional investors. Book with your work email.
Frequently Asked Questions
Common questions about Conceivable Life Sciences's valuation, stock price, and market status.
Is Conceivable Life Sciences a public or private company?
Conceivable Life Sciences is a private company.
What is the current stock price of Conceivable Life Sciences?
Conceivable Life Sciences is a private company, so its shares have no public market price. Caplight tracks Conceivable Life Sciences's secondary market activity and provides MarketPrice™ estimates of its share price to Caplight users.
How much is Conceivable Life Sciences worth (valuation)?
Valuation information for Conceivable Life Sciences is not publicly available.
Can I buy Conceivable Life Sciences stock?
Conceivable Life Sciences shares may be available on secondary markets subject to transfer restrictions. Caplight facilitates secondary market transactions for accredited investors.
When was Conceivable Life Sciences's last funding round?
Conceivable Life Sciences's most recent funding round was Series A on August 5, 2025.
Who are the main investors in Conceivable Life Sciences?
Key investors in Conceivable Life Sciences include ARTIS Ventures, Advance Venture Partners.
Will Conceivable Life Sciences IPO soon?
No public IPO plans have been announced for Conceivable Life Sciences.
How can I track Conceivable Life Sciences secondary market activity?
Caplight tracks bids, offers, and trades in Conceivable Life Sciences's shares on secondary markets.